Weize Zhu

752 total citations · 1 hit paper
12 papers, 423 citations indexed

About

Weize Zhu is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Weize Zhu has authored 12 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Weize Zhu's work include Gut microbiota and health (9 papers), Liver Disease Diagnosis and Treatment (6 papers) and Diet and metabolism studies (5 papers). Weize Zhu is often cited by papers focused on Gut microbiota and health (9 papers), Liver Disease Diagnosis and Treatment (6 papers) and Diet and metabolism studies (5 papers). Weize Zhu collaborates with scholars based in China, Hong Kong and United States. Weize Zhu's co-authors include Houkai Li, Ningning Zheng, Lili Sheng, Ying Hong, Junli Ma, Jing Zhong, Gaosong Wu, Juan Yan, Xin Tao and Kan Ding and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Environmental Pollution and Journal of Ethnopharmacology.

In The Last Decade

Weize Zhu

11 papers receiving 420 citations

Hit Papers

Desulfovibrio vulgaris, a potent acetic acid-producing ba... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weize Zhu China 8 287 111 98 47 45 12 423
Juan Yan China 7 264 0.9× 104 0.9× 92 0.9× 42 0.9× 46 1.0× 10 379
Ziqiong Liao China 8 288 1.0× 47 0.4× 82 0.8× 39 0.8× 23 0.5× 10 392
Wanping Aw Japan 15 310 1.1× 59 0.5× 132 1.3× 72 1.5× 60 1.3× 23 557
Chien-Chao Chiu Taiwan 13 254 0.9× 140 1.3× 201 2.1× 38 0.8× 49 1.1× 18 595
Aizhen Lin China 9 320 1.1× 136 1.2× 129 1.3× 78 1.7× 61 1.4× 11 571
Yizhe Cui China 12 244 0.9× 158 1.4× 61 0.6× 55 1.2× 65 1.4× 20 486
Jiyeon Kim South Korea 8 326 1.1× 50 0.5× 149 1.5× 44 0.9× 55 1.2× 18 437
Geoffrey Y. Sasaki United States 11 220 0.8× 106 1.0× 94 1.0× 42 0.9× 45 1.0× 17 459
Zhimiao Zhang China 7 280 1.0× 44 0.4× 69 0.7× 35 0.7× 24 0.5× 10 410

Countries citing papers authored by Weize Zhu

Since Specialization
Citations

This map shows the geographic impact of Weize Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weize Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weize Zhu more than expected).

Fields of papers citing papers by Weize Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weize Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weize Zhu. The network helps show where Weize Zhu may publish in the future.

Co-authorship network of co-authors of Weize Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Weize Zhu. A scholar is included among the top collaborators of Weize Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weize Zhu. Weize Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Wang, Hao, Weize Zhu, Ying Hong, et al.. (2024). Astragalus polysaccharides attenuate chemotherapy-induced immune injury by modulating gut microbiota and polyunsaturated fatty acid metabolism. Phytomedicine. 128. 155492–155492. 32 indexed citations
3.
Li, Yifan, Hao Wang, Xiaofang He, et al.. (2024). Zhi-Kang-Yin formula attenuates high-fat diet-induced metabolic disorders through modulating gut microbiota-bile acids axis in mice. Chinese Medicine. 19(1). 145–145. 3 indexed citations
5.
Zheng, Ningning, Hao Wang, Weize Zhu, Yan Li, & Houkai Li. (2023). Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice. Journal of Ethnopharmacology. 320. 117401–117401. 23 indexed citations
6.
Zhu, Weize, Siyuan Lu, Haibo Jiang, et al.. (2023). Interactions between phenanthrene and polystyrene micro/nano plastics: Implications for rice (Oryza sativa L.) toxicity. Environmental Pollution. 337. 122360–122360. 11 indexed citations
7.
Ma, Junli, Zekun Liu, Xinxin Gao, et al.. (2023). Gut microbiota remodeling improves natural aging-related disorders through Akkermansia muciniphila and its derived acetic acid. Pharmacological Research. 189. 106687–106687. 86 indexed citations
8.
He, Xiaofang, Xinxin Gao, Ying Hong, et al.. (2023). High Fat Diet and High Sucrose Intake Divergently Induce Dysregulation of Glucose Homeostasis through Distinct Gut Microbiota-Derived Bile Acid Metabolism in Mice. Journal of Agricultural and Food Chemistry. 72(1). 230–244. 10 indexed citations
9.
Zhu, Weize, Ying Hong, Yue Li, et al.. (2022). Microbial and Transcriptomic Profiling Reveals Diet-Related Alterations of Metabolism in Metabolic Disordered Mice. Frontiers in Nutrition. 9. 923377–923377. 6 indexed citations
10.
Zhong, Jing, Dingfeng Wu, Gaosong Wu, et al.. (2022). The Microbial and Metabolic Signatures of Patients with Stable Coronary Artery Disease. Microbiology Spectrum. 10(6). e0246722–e0246722. 15 indexed citations
11.
Chen, Linlin, Juntao Kan, Ningning Zheng, et al.. (2021). A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation. Phytomedicine. 91. 153693–153693. 25 indexed citations
12.
Hong, Ying, Lili Sheng, Jing Zhong, et al.. (2021). Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. Gut Microbes. 13(1). 1–20. 207 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026